Woodlands, Texas-based Opexa Therapeutics, Inc. recently renounced that it will partner with the National Multiple Sclerosis Society‘s Lone Star Chapter this year and serve as a sponsor of the Houston-area Walk MS. This is the forth consecutive year that the biopharmaceutical company will sponsor the nonprofit’s annual event, which seeks to help more than 68,000 patients with MS in Texas. Throughout October and November, the Houston-area fundraisers will consist of four local walks and fundraising events, one of which will take place at Opexa’s corporate headquarters in The Woodlands.
Opexa is a biopharmaceutical company that develops personalized immunotherapies to treat diseases with unmet needs, including multiple sclerosis (MS). The company’s therapies are based on T-cell technology, with its lead therapeutic candidate Tcelna® acting as a T-cell immunotherapy that can be personalized to treat Secondary Progressive MS. Tcelna derives from isolated T-cells that, when reintroduced into patients, triggers a strong immune response against T-cells that attack myelin.
“Opexa is proud to be a partner of the National MS Society’s Houston area Walk MS events,” said Neil K. Warma, Opexa’s President and Chief Executive Officer in a press release. “We are committed to helping the Society support critical programs and services to improve the quality of life for people affected by MS. We are dedicated to developing a personalized therapy for Secondary Progressive MS, and these events offer the unique opportunity for those of us in the Company to meet people living with MS and their families, which provides us with tremendous motivation.”
Walk MS connects people living with MS with those seeking to advocate and support research for the disease. It is an important event in particular for the MS Movement, an international community raising funds and hope for the future of more than 2.3 million people worldwide that live side by side with MS. In 2013, the events throughout the South Central Chapter territory attracted more than 25,000 participants, and more than $3.2 million was raised and given the National Multiple Sclerosis Society. More than 300,000 people participate in Walk MS every year, and the event raises over $50 million per year, which can in turn be invested in helping MS patients live with the disease. Since 1988, throughout the entire country, more than $870 million has been raised to support programs and to develop cutting-edge technologies and therapies.